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Summary 
The mouse thymus was assessed for its ability to produce steroids. Cultured thymic non-T cells 
produced soluble pregnenolone and deoxycorticosterone, and immunohistochemistry demonstrated 
steroidogenic enzymes in radioresistant thymic epithelial cells but not in thymocytes. Inhibition 
of thymic corticosterone production or blockade of the ghcocorticoid receptor with RU-486 
resulted in enhanced TCR-mediated, antigen-specific deletion of immature thymocytes. These 
data indicate that locally produced glucocorticoids, because of their antagonism of TCR-mediated 
signaling  for death, may be a key element of antigen-specific thymocyte sdection. 
D 
eveloping thymocytes undergo selection based upon the 
ability of their clonally distributed TCRs to recognize 
self-antigens associated with MHC-encoded molecules (1). 
The mechanistic basis for selection is unknown, but it is gener- 
ally thought to depend upon the avidity of the TCR for self- 
molecules (2, 3). Thymocytes whose TCRs have inadequate 
avidity for self-andgen/MHC die within the thymus, whereas 
those whose TCKs have high avidity, and are thus poten- 
tially harmful,  are  negatively  selected and undergo pro- 
grammed ceil death (apoptosis). Thymocytes whose TCKs 
have moderate avidity for sdf-antigen/MHC survive (posi- 
tive selection) and develop into the T cells that populate the 
periphery. How ligand recognition by one receptor can lead 
to two such different fates, death vs. survival and expansion, 
is an unresolved paradox. 
In addition to occupancy of the TCK, glucocorticoids are a 
potent means of inducing thymocyte apoptosis (4, 5). The 
thymocytes most sensitive to the lethal effects of glucocor- 
ticoids  are the same that undergo selection:  CD4+CD8 + 
(double positive) immature cells located in the cortex; med- 
ullary CD4 +  CD8-  and CD4- CD8 + (single positive) ceils, 
like peripheral T cells, are relatively resistant (6, 7). Ahhough 
no dearly defined role has been elucidated  for steroids in 
thymocyte development, there is reason to believe that such 
an influence might exist. Stress-induced increases in circulating 
glucocorticoids cause thymus involution (8,  9),  and adre- 
nalectomy in adult animals results in thymus hypertrophy 
(10). Surprisingly, although both stimuli are lethal by them- 
selves, glucocorticoids and TCK-mediated signals prevent 
each other's induction of T cell hybridoma and thymocyte 
programmed ceil death in vitro (mutual antagonism), prompt- 
ing us and others to speculate that the balance of these two 
stimuli may in part regulate the process of thymocyte sdec- 
tion (11-13). One difficulty with such a modal is that the 
level of circulating glucocorticoids during neonatal life, a 
time during which thymocyte selection is particularly active, 
is very low (14, 15). It is intriguing in this regard that there 
is accumulating evidence that the thymus has endocrine prop- 
erties. The neuropeptides  oxytocin and vasopressin (16), as 
well as insulin-like growth factors (17, 18), are produced by 
thymic epithelial cells. The thymus has also been found to 
express corticotropin-releasing  factor  (CRF) 1 (19) and ad- 
renocorticotrophic hormone (ACTH) (20),  a peptide that 
induces glucocorticoid production in adrenal cortical ceils (21). 
Given these observations,  we asked if the thymus can pro- 
duce steroids, and if so, whether locally produced steroids 
influence TCR-directed thymocyte sdection. 
Materials and Methods 
MIC~  BALB/c mice were obtained from the Developmental 
Therapeutics Program, NCI (Frederick,  MD). In some  experiments, 
mice were sublethaUy  irradiated (600 cGy, Gammacel140;  Atomic 
Energy of Canada, Kanata, Ontario, Canada) 4 d before killing 
and removal of the thymus. 
Media and Reagents.  In fetal thymic organ cultures and steroid 
synthesis assays, HL,1, a serum- and corticosteroid-free  medium 
(Ventrex Hycor, Portland, ME) was supplemented  with penicillin, 
0.015% g-glutamine, 100 mM nonessential amino acids, 1 mM 
sodium pyruvate,  20 mM Hepes, 250/~g/ml gentamicin,  and 50/~M 
1 Abbreviations used in this paper: ACTH, adenocorticotrophic hormone; 
CRF, corticotropin-releasing factor. 
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modified Dulbecco's medium plus 10% fetal calf serum was used. 
RU-486 was the generous gift of E.  E. Baulien (Universit6  de 
Paris-Snd, Paris, France).  Trilostane,  an inhibitor of 3~HSD, was 
obtained from Sterling Drug, Inc. (Rensselaer,  NY), and amino- 
glutethimide, an inhibitor of P450scc, was obtained from Ciba-Geigy 
Corp.  (Summit,  NJ).  Antisera  to pregnenolone and deoxycor- 
ticosterone, and [~H]pregnenolone and [3H]deoxycorticosterone, 
were purchased from ICN (Irvine, CA). 22R-hydroxycholesterol 
and ACTH fragment 1-24 was obtained from Sigma Chemical Co. 
(St. Louis,  MO). Metyrapone was purchased from ICN. All re- 
agents for immunohistochemistry were purchased from Zymed 
Laboratories In~ (S. San Francisco, CA). Anti-P450scc, anti-P450c11, 
and anti-P450aromatase (Oxygene Dallas,  Inc., Dallas,  TX) and 
anticytokeratin (Boehringer-Mannheim Corp., Indianapolis,  IN) 
were used for immunohistochemistry. GK1.5 (anti-CD4 [22]), 53- 
6.7 (anti-CD8 [23]) were used to stain thymocytes, and 30H12 (anti- 
Thy-l.2 [23]) plus complement was used to deplete thymocytes. 
Radioimmunoassays.  For secreted steroids, thymi were isolated 
from 3-wk-old BALB/c mice, minced finely, and treated with col- 
lagenase  solution (0.5 mg/ml collagenase,  0.5 mg/ml dispase, 4 
#g/ml DNase) at 37~  until no fragments remained. Cells were 
washed and titrated numbers were cultured in supplemented HL-1 
medium. For some experiments the medium was supplemented with 
6.25 #M 22K-hydroxycholesterol, 10 nM ACTH fragment 1-24, 
and 50 #M trilostane. Cultures were performed in triplicate and 
maintained  at 37~  with 5% CO2 for 4 d. Supernatants  were col- 
lected at 4 d, stored at  -20~  and pregnenolone concentrations 
determined by RIA (ICN).  For measurement of mitochondrial 
steroids, mitochondria were prepared and assayed for P450scc ac- 
tivity as described (24). Briefly, tissues were crushed and collagenase- 
treated to a single cell suspension,  then homogenized in 250 mM 
sucrose/10 mM Tris, pH 7.4. Homogenates were centrifuged at 
800 g for 10 min to pellet nuclei, then supematants centrifuged 
at 10,000 g for 15 min.  Mitochondrial pellets were resuspended 
in a solution containing 250 mM sucrose, 10 mM K2HPO4, 5 mM 
MgC12, 15 mM triethanolamine-HC1, 20 mM KCI, and 5 #M 
trilostane.  Equal amounts of mitochondrial protein were incubated 
with15 mM malate and 0.5 mM NADP, with or without 25 #M 
22R-hydroxyeholesterol, for 12 h at 37~  in 100 #1. The reaction 
was stopped with 500 #1 of ice-cold ethanol and extracted 3 times 
with 2.5 volumes of hexane.  The ethanol fraction was collected 
and evaporated.  The pellet was resuspended and assayed for preg- 
nenolone. RIAs for pregnenolone and deoxycorticosterone were 
performed according to the manufacturer's instructions. 
Imraunohistochemistry.  Tissue and  slide  preparation was per- 
formed as described (25). Briefly, thymi were placed in Bouin's so- 
lution for 24 h. Tissues were dehydrated with increasing concen- 
trations of ethanol (70,  90,  95,  and 99%) at 1-h intervals,  then 
placed in 100% ethanol. Tissue embedding and sectioning was per- 
formed by American Histolabs (Gaithersburg, MD). 5-micron sec- 
tions were placed on silanated slides. Before staining, the slides were 
dewaxed in xylene for 5 min, then rehydrated in decreasing con- 
centrations of ethanol (95, 90, and 70%) for 10-min intervals. The 
final concentration of 70% ethanol had 1% LiCO3 to remove the 
picric acid remaining from the Bouin's solution. Slides were in- 
cubated in 300 mM glycine in PBS, then 1% BSA in PBS for 5 
min each. Slides were then incubated with periodic acid (Zymed 
Laboratories, Inc.) for 45 s to block endogenous peroxidase activity, 
followed by 10-rain incubations each with avidin and biotin (Zymed 
Laboratories,  Inc.).  Antibody staining was performed with the 
Histostain-SP  kit  (Zymed Laboratories,  Inc.)  according  to  the 
manufacturer's instructions, with the primary antibody incubation 
lasting for 3 h. Primary antibodies were used at the following con- 
centrations: rabbit Ig (Zymed Laboratories, Inc.) 1:100; anti-P450scc 
1:15; and anti-P450c11  1:15 (both from Oxygene Dallas).  Slides 
were counterstained with hematoxylin. The anti-P450scc and anti- 
P450cll antibodies stained adrenal tissue intensely but did not stain 
fibroblasts  (data not shown). 
Enrichment of Thymic Cell Subsets.  Thymic epithelial cells and 
thymic rosettes, containing macrophages and dendritic cells, were 
isolated by the procedure of Kyewski et al. (26). Briefly, thymi were 
digested with 0.5 mg/ml collagenase at room temperature,  followed 
by digestion with collagenase/dispase  (0.5 mg/ml collagenase, 0.5 
mg/ml dispase, 4 #g/ml DNase) at 37~  Those cells released by 
the collagenase digestion (T-ros) were collected and kept separate 
from those released by cullagenase/dispase/DNase digestion (epi- 
thelial  ceils).  The two groups of cells were subjected to gravity 
sedimentation over a fetal calf serum gradient four times to enrich 
for macrophages and dendritic cells or epithelial  cells. 
Flow Cytometry.  Staining was performed with GK1.5-biotin and 
53-6.7-FITC.  Flow  cytometric analysis  was  performed with  a 
FACScan  |  (Becton Dickinson & Co., Mountain View,  CA). 
Fetal Organ Culture.  Fetuses (day 15.5 to day 16) were obtained 
from 12-h timed pregnant BALB/c mice mated in our animal fa- 
cility.  The day of the vaginal plug was considered day 0. Thymi 
were removed and split into 2-4 pieces each. Individual fragments 
were placed on a filter (Millipore Corp., Bedford, MA) floating 
on a gelfoam sponge in complete Hbl  medium.  Cultures were 
carried out in 1.5 ml of media/well in 12-well plates.  Fragments 
were cultured either alone or with 20 #g/ml of H57 (anti-TCR 
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Figure  1.  Schematic  of some of the steps in stetoidogenesis.  Many of the 
steroidogenic enzymes belong to the P450 cytochrome family. Rodents 
have little or no P450c17 in the adrenal gland, so the major circulating 
glucocorticoid is corticosterone (49). P450scc and P450cll/P450aldo are 
located in mitochondria. P450cll and P450aldo are isoenzymes.  Enzymes 
are boxed, inhibitors are underlined. 
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Figure  2.  Synthesis  of pregnenolone in whole and T-depleted thymus cell populations. (a) Thymi 
were isolated from 3-wk-old BALB/c mice and cultured in triplicate in HL-1 medium supplemented 
with 6.25/~M 221L-hydroxycholesterol, 10 nM ACTH fragment  1-24, with or without 50/zM 
trilostane. After 4 d, supematants were collected and pregnenolone concentrations determined.  (b) 
Pregnenolone secretion by 4  x  106 cells from collagenase-treated thymus or from collagenase-treated 
thymus after T cell depletion by an anti-Thy-l.2 antibody, 30H12, plus complement in the presence 
of 22R-hydre0~holesterol,  ACTH, and trilostane. (c) 106 cells from 3-wk-old BALB/c collagenase- 
treated normal thymus or thymus from animals sublethaly irradiated 4 d previously were cultured 
for 4 d with 6.25/~M 22K-hydroxycholesterol and 10 nM ACTH, either in HL-1 medium alone 
or in the presence of 50 ~M trilostane, without or with aminoghtethimide, and the supernatants 
analyzed for pregnenolone. (d) Mitochondria were isolated from the indicated tissues from 3.5-wk- 
old BALB/c mice that had or had not been treated with sublethal 'y-radiation 4 d before killing. 
(e) Colhgenase-treated  thymus cells (4.5  x  106) or collagenase-treated thymus ceils depleted of 
thymocytes with anti-Tby-l.2 plus complement (4.5  x  106)  were incubated for 4 d in I-I~l medium 
supplemented with 6.25/~M 221~,-hydre~-ycholesterol  and 30 nM ACTH. After 4 d, supematant 
was collected and assayed for deoxycorticosterone  in duplicate. (~ 10  s colhgenase-treated  thymus 
cells ~  cultured for 4 d in the absence or presence of 6.25/~M 22R-hydroxycholesterol,  titrated 
levels of ACTH, and 50/~M trilustane.  (g) 5  x  10  s thymic epithelial cells, thymocytes, or T-ros 
(macrophages  and  dendritic  cells) were  cultured  with  10  nM  ACTH  and  6.25  /~M  22R- 
hydroxycholesterol in the presence or absence of 50 #M trilostane for 6 d. Supematants  were har- 
vested and assayed for pregnenolone.  Error bars represent SE of triplicate cultures except in b, d, 
and f, where they represent the standard deviation  of assays performed in duplicate. 
C/~), with or without 150/~g/ml of metyrapone for 3 d at 37~ 
Fragments were harvested and made into single cell suspensions 
for staining. 
Deletion of H-Y-specific Thymocytes.  Preparation of thymic APC 
monolayers and in vitro induction of apoptosis was performed as 
previously described by Swat et al. (27). 2  x  106 thymocytes from 
D  -restricted transgenic mice (28) of the H-2  b  female H-Y-specific  b 
haplotype were cultured  in supplemented Iscove's modified Dul- 
becco's medium for 36 h  in  the absence or presence of 10 .7 M 
RU-486. Harvested thymocytes were stained with GK1.5-biotin 
(anti-CD4)  and  53-6.7-FITC  (anti-CDS).  The  small,  dying 
CD4kCD8  b cells were gated out so that the remaining CD4hCD8  ~ 
cells  could be better visualized. 
Results 
Steroid Synthesis by the Thymus.  The  rate  determining 
step in steroidogenesis is availability  of the substrate choles- 
terol at the inner mitochondrial membrane, where it is metabo- 
lized to pregnenolone by the enzyme p450scc  (Fig.  1).  To 
determine if the thymus can produce steroids,  collagenase- 
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tants were assayed for pregnenolone, the precursor of all 
other steroids. The cultures were done in serum-frce medium 
to eliminate any exogenous steroids. The cultures were sup- 
plemented with the water-soluble cholesterol analog 22R- 
hydroxycholesterol,  to  provide  a  nonlimiting  source  of 
cholesterol, and ACTH, which increases mobilization of cho- 
lesterol from intracdlular stores to the inner mitochondrial 
membrane and upregulates expression of P450 enzymes (21). 
Pregnenolone was not detected under these conditions (Fig. 
2 a). However, in the presence of trilostane, a competitive 
inhibitor of 3flHSD that prevents further metabolism ofpreg- 
nenolone, pregnenolone  was readily detected and was depen- 
dent on the number of cultured cells. To determine the source 
of the pregnenolone, its production by coHagenase-treated 
thymus cells was determined before and after specific deple- 
tion of thymocytes by antibody plus complement. At the 
cell numbers used (4  x  106 cells/well), no detectable preg- 
nenolone  was produced  by a population overwhelmingly  com- 
posed of thymocytes, even in the presence of trilostane. After 
thymocyte  depletion with anti-Thy-1 antibody plus comple- 
ment, the same number of cells produced easily detectable 
levels of pregnenolone (Fig.  2 b). 
Because of the technical difficulties of quantitatively de- 
pleting very large numbers of thymocytes  with antibody plus 
complement, further analyses were performed with thymi 
Figure 3.  Expression of the ste- 
roidogenic  enzymes  P450scc and 
P450cll  in mouse  thymus.  (a--c) 
400x  magnification  of serial sec- 
tions of a thymus from a 3-wk-old 
BALB/c mouse. Anti-P450scc (a), 
anti-P450c11 (b), or control rabbit 
antibody  (c) were  used  to stain  serial 
section~  which  were  de~oped  with 
an indirect  analogy  a~! peroxidase. 
The peraxidase reaction results in 
the formation of a red precipitate. 
enzymes  in  thymus  depk~d  of 
tbymoo~  by sublethal  ir~iation. 
Rabbit Ig (d, 50x  magnification) 
and anti-P4S0scc  senan  (e, 50￿  ;f, 
100x,g, 200￿  ~).  Note 
that the serial sections are 5 micron 
in diameter,  and so  not all  cells 
found in one section will be repre- 
sented in the adjacent section. 
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which resulted in loss of ~98% of thymocytes.  106 cultured 
collagenase-treated thymus cells did not produce detectable 
pregnenolone (Fig. 2 c). In contrast, pregnenolone was easily 
detectable in cultures of 10  ~ thymus ceils that were depleted 
of T  cells by low dose irradiation.  Moreover,  inclusion of 
aminoglutethimide, an inh;bitor of P450scc (Fig.  1), abol- 
ished pregnenolone synthesis.  Steroid production was also 
measured in isolated mitochondria from adrenal and thymus 
cells. After 16 h of culture with or without 22R-hydroxy- 
cholesterol,  supernatants  were analyzed for the presence of 
pregnenolone. One representative experiment of five is shown 
in Fig. 2 d. Low but significant levels of pregnenolone were 
detected in adrenal mitocbondria from untreated animals, and 
increased sharply in the presence of 22R-hydroxycholesterol. 
Adrenal mitochondria from sublethally irradiated mice pro- 
duced less pregnenolone than cells from untreated animals, 
arguing that the irradiation did not itself activate P450scc. 
No pregnenolone was  detected when mitochondria from 
collagenase-treated thymus cells were assayed, but substan- 
tial amounts va:re found when T-depleted and collagenase- 
treated thymus cells from previously irradiated animals were 
used.  Since the amount of mitochondrial protein used per 
group was constant, the detection of pregnenolone in T-de- 
pleted  thymus is consistent  with enrichment of radioresis- 
tant epithelial ceils. In addition to demonstrating that preg- 
nenolone can be synthesized by radiation-resistant thymic cells, 
these results  indicate  that  pregnenolone produced in  the 
thymus is further metabolized by 3~HSD, since trilostane 
caused accumulation of pregnenolone. We also detected deoxy- 
corticosterone in supernatants of collagenase-treated thymus 
cells after depletion of thymocytes by antibody plus comple- 
ment  (Fig.  2 e). 
The effect of ACTH on steroid production in the thymus 
was determined (Fig. 2J). Pregnenolone was produced only 
when its precursor,  22I~.-hydroxycholesterol, was provided. 
Moreover, ACTH caused a dose-dependent increase in ste- 
roid biosynthesis. Pregnenolone production was not further 
increased by ACTH concentrations of >30 nM. Therefore, 
as for the adrenals, thymic steroid-producing cells are respon- 
sive to ACTH. 
Expression of  Steroidogenic  Enzymes in the Thymus.  Thymi 
from 3-wk-old BALB/c mice were sectioned and immuno- 
histochemistry was used to detect expression of the steroido- 
genesis enzymes P450scc and P450c11, which are responsible 
for the synthesis of pregnenolone and corticosterone,  respec- 
tively (Fig. 1). Expression of P450scc is the determlnlng factor 
in whether a tissue is capable of steroidogenesis; it has been 
found only in tissues with steroidogenic  capabilities,  such 
as the adrenal gland, placenta,  sex organs (29-31),  and re- 
cently the brain (32).. The antiserum to P450scc specifically 
stained a subset of thymic cells (Fig. 3). The large size and 
abundant cytoplasm suggested that these cells are not thymo- 
cytes. Areas of the serial sections that stained brightly with 
anti-P450scc also stained specifically  with anti-P450cll (Fig. 
3 b). This was not due to cross-reactivity of the P40c11-specific 
antiserum with P450scc or other P450 enzymes, since it did 
not stain MA-10 (33), a mouse tumor Leydig cell line that 
produces testoste~nr but not glucocorticoids  (data not shown). 
Visualization of the steroidogenic enzym~ssing  cells was 
obscured by the large number of enzyme-negative thymo- 
cytes. To eliminate these cells, mice were sublethally irradi- 
1839  Vacchio et al. Figure 4.  Expression  of P450scc in the thymus. Serial sections of thymus from a 3-wk-old BALB/c mouse were stained with anfi-P450scc (a), an- 
ticytokeratin (b), or rabbit Ig (c). Serial sections of BALB/c fetal thymus (day 19) were stained with rabbit Ig (d) or anti-P450scc  (e). Staining was 
performed as described for Fig. 3, except that slides stained for cytokeratin (a-c) were trypsin-treated for 40 min at 37~  after the glycine incubation. 
The primary antibodies were used at the following concentrations: rabbit Ig 1:100; anti-P450scc  1:15; anticytokeratin 1:100. 
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matically reduced the number of thymocytes and enhanced 
visualization of the radiation-resistant  stromal elements (Fig. 
3, d-g). Diffuse and specific staining with the anti-P450scc 
antiserum was seen throughout the thymus, most notably 
in the cortex. In addition, scattered intensely staining cells 
were found primarily in the cortex, although a small number 
were also observed in the medulla. Similar staining was ob- 
served with anti-P450cll antiserum (data not shown). Nei- 
ther normal rabbit serum antiserum (Fig.  3 d) nor an an- 
tiserum against P450aromatase (data not shown), an enzyme 
involved in estrogen but not glucocorticoid biosynthesis, 
stained these cells. To determine the identity of the radioresis- 
tant cells, serial sections of thymus were stained with either 
epithelial cell-specific anticytokeratin or anti-P450scc  anti- 
bodies.  As shown in Fig. 4, cells positive for P450scc (Fig. 
4 a) also stained with anticytokeratin (Fig. 4 b). As expected, 
cells that stained with anticytokeratin were ubiquitous in dis- 
tribution in thymi from sublethally irradiated mice (data not 
shown), in which visualization of epithelial cells was greatly 
enhanced by elimination of thymocytes, indicating that the 
P450scc-positive  cells represent a small subset of epithelial 
cells. In addition, studies with a thymic epithelial cell line, 
TEC (34), found that it stained specifically with antisera to 
P450scc  and  P450c11,  but  not  P450aromatase  (data  not 
shown). Thus, enzymes necessary for steroid synthesis are 
present in the thymus, and appear to be expressed in radio- 
resistant  epithelial cells, and at particularly high levels in a 
subpopulation found predominantly in the cortex, although 
a small population of P450scc + nonepithelial cells cannot be 
excluded. 
Steroid Production by Thymic Epithelial Cells.  Thymic epi- 
thelial cells, especially so-called thymic nurse cells, can be sepa- 
rated from thymic macrophages and dendritic cells (thymic 
rosettes) and isolated by sedimentation through serum (35). 
When these populations were cultured for 6 d, a small amount 
of pregnenolone was detected in cultures of epithelial cells 
in medium alone, which increased '~10-fold in the presence 
of trilostane (Fig. 2 g). Although T-rosettes had a slightly 
higher baseline activity,  the levels of pregnenolone did not 
increase with trilostane and were significantly lower than that 
seen with the epithelial cells. This may be a result of contam- 
ination of epithelial cells in the T-rosette cultures and/or a 
limited but significant ability of cells in the T-rosettes to syn- 
thesize pregnenolone. In any case, these results demonstrate 
that enrichment of thymic epithelial cells also enriches for 
steroid production. 
Ontogeny of Thymic Steroid Production.  Circulating levels 
of glucocorticoids in rats are low to undetectable until 2 wk 
after birth, increasing thereafter to adult levels by 4 wk of 
age (14). If steroids play a major role in thymocyte selection, 
steroid production in the thymus would be expected to differ 
from that by the adrenals,  since thymocyte selection  starts 
during fetal development. To test this, thymi from fetal thymic 
organ culture were sectioned and stained for the presence 
P450scc; large,  positively staining cells were found (Fig. 4 
e). The capacity of thymi from mice of different ages to pro- 
duce steroids was quantitated using thymi taken from mice 
in four age groups: day 17 of fetal development to 1 d after 
birth,  10-14  d old, 28 d old, and 84 d old. Pregnenolone 
was measured from cultures of collagenase-treated, T-depleted 
thymus cells. Cells from the youngest mice produced detect- 
able levels of pregnenolone that were markedly augmented 
by the inclusion of trilostane (Fig.  5). Production of preg- 
nenolone was slightly decreased at 2 wk of age, and was 50% 
lower by 4 wk of age. Similar experiments performed with 
isolated adrenal cells found the opposite: that production of 
steroids was initially low and increased after birth (our un- 
published observation). Thus, the thymus can produce the 
greatest amount of steroids during fetal development and early 
life, and the levels decrease with age. 
Thymus-derived Steroids and Activation.induced Thyraocyte De- 
letion.  Fetal  thymic organ cuhures were used to evaluate 
whether steroids synthesized in the thymus influence TCR- 
mediated thymocyte selection. Anti-TCR antibodies induce 
apoptosis in CD4+CD8 + thymocytes, which is thought to 
mimic TCR-mediated negative sdection (36). Day 16 fetal 
thymi were cultured in serum-free medium with H57-597 
(H57), a CB-spedfic antibody (37),  in the presence or ab- 
sence of the P450cll inhibitor, metyrapone. One representa- 
tive experiment is shown in Fig. 6, and Tables 1 and 2 con- 
tain data from multiple experiments. Culture with H57 alone 
resulted in a 32% decrease in CD4+CD8 + thymocytes (78.9 
"-* 53.3%). Although at this concentration metyrapone alone 
had little effect (Table 1), when added with H57 there was 
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Figure  5.  Effect of age on synthesis of steroids in the thymus.  Thymi 
from 25 mice aged fetal day 17-1 d, 10-14 d, 28 d, or 84 d were collagenase- 
treated and T-depleted. Single cell suspensions were treated with anti-Thy- 
1.2 plus complement. Such treatment consistently  resulted  in 0.5-2% 
recovery of starting cell number.  106 cells were cultured for 5 d with 10 
aM ACTH and 6.25/~M 22R-hydroxycholesterol  in the absence or pres- 
ence of 50/~M trilostane. Supernatants were harvested and assayed for preg- 
nenolon~ Analysis  by FACScan  |  before initiation of cultures revealed  equiva- 
lent depletion  of thymocytes in each culture (<1% of cells stained with 
anti-CD4 or anti-CDS). 
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Figure 6.  Blockade of  steroid 
biosynthesis  and anti-TCR-induced 
deletion of CD4+CD8  + thymo- 
cytes. Day 15.5-16 fetal  thymi  were 
cultured for 3 d in medium alone 
(a),  anti-TCK antibody (b), anti- 
TCR antibody  plus metyrapone  (c), 
and anti-TCK  antibody  plus metyra- 
pone plus corticosterone (d). 
cytes of 66% (78.9 ~  27.2%) (Table 1, Expt.  1). The en- 
hanced deletion seen in the absence  of corticosterone was 
reversed  by inclusion of 10 -9  M  corticosterone (Table  1, 
Expt, 2); lower concentrations ofcorticosterone were ineffec- 
tive (data not shown). Additional experiments were performed 
with RU-486, a competitive glucocorticoid antagonist (38). 
Culture of thymocytes in medium or with RU-486 resulted 
in a normal fraction of CD4+CD8 + thymocytes (75-80%). 
Treatment with H57 caused a 25% decrease in CD4+CD8 + 
thymocytes (79.0  ~  59.2%); addition of RU-486 resulted 
in a 50% decrease (79.0 ~  39.5%) (Table 1, Expt. 3). Similar 
results were obtained with 145-2Cll, an anti-CD3 mAb, and 
coculture with metyrapone or RU-486 (our unpublished ob- 
servations).  The effect of metyrapone on anti-TCR-induced 
thymocyte  depletion was also evident in terms of  cell recovery. 
As demonstrated in another experiment (Table 3), metyra- 
pone enhanced TCR-mediated deletion by almost 50%,  a 
response that was completely reversed by the addition of cot- 
ticosterone. Increasing the concentration of metyrapone in 
the absence of antibodies caused a reduction in the number 
of CD4 +CD8 + thymocytes and prevented the appearance of 
CD4+CD8 -  single positive thymocytes; this effect was also 
reversed by the addition of corticosterone (data not shown). 
Culture of thymocytes from H-Y-specific TCR transgenic 
female mice with  male thymic APC  monolayers induces 
apoptosis,  as detected by loss  of CD4+CD8 + thymocytes 
expressing high levels of CD4 and CD8, and the appearance 
of CD4]~176  cells  that  are  actively fragmenting  their 
DNA (27). Thymocytes  from female H-Y-specific TCR trans- 
genic mice were cultured for 36 h alone or with APCs from 
either B6  female (H-Y-),  BALB/c female (H-Y-),  or B6 
male (H-Y +) mice (Table 2). Culture of female thymocytes 
alone or with female APC and with or without RU-486 had 
little effect on the percentage of CD4~CD8  hi cells. In the 
experiment summarized in Table 2,  culture of B6  female 
thymocytes with B6 male APCs caused a small decrease in 
Table  1.  Inhibition of TCR-mediated Thymocyte Deletion by Locally Produced Steroids 
Percent CD4 +  CD8 + thymocytes 
Medium  Corticosterone 
10 -9 M 
Expt.  1 Medium  78.9  _+  1.7  ND 
Metyrapone  74.7  +  2.4  ND 
Anti-TCR  53.3  _+  4.8  ND 
Anti-TCR  +  metyrapone  27.2  _+  6.8  ND 
Expt.  2 Medium  69.2  _+  7.6  72.9  _+  0.9 
Anti-TCR  53.2  +  3.1  59.4  +  2.0 
Anti-TCR  +  metyrapone  13.2  +  2.2  52.5  _+  3.2 
Expt.  3 Medium  79.0  _+  3.4  ND 
RU-486  76.0  _+  4.2  ND 
Anti-TCR  59.2  _+  3.3  ND 
Anti-TCR  +  RU-486  39.5  _+  5.9  ND 
Results are expressed as the arithmetic mean of seven (Expt. 1), four (Expt. 2), or eight (Expt. 3) individual animals, and SEM are shown. To 
avoid animal-to-animal  variability, each thymus  was divided  into three or four pieces that received the indicated  treatments. ND, not determined. 
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Percent  CD4h~D8 hl thymocytes 
Thymic APC  Medium  KU-486  RU-486 
(10-7M)  (5  ￿  lo-7 ~ 
B6 female  31.5  _+  1.9  28.7  __  0.7  32.3  ,+  3.8 
B6  male  27.0  _+  3.4  18.7  _+  4.4  13.2  _+  4.1 
BALB/c female  32.0  _+  1.6  29.0  _+  1.1  26.5  _+  4.3 
None  32.3  _+  3.3  30.1  _+  1.3  35.4  _+  1.6 
Deletion of H-Y-specific thymocytes was measured  as described in Materials  and Methods. Each data  point is the mean of triplicate  cultures,  and 
SEM are shown. 
the number of CD4hiCD8 hi thymocytes (31.5  -*  27.0%) 
that  was  greatly  enhanced  by  the  addition  of RU-486 
(28.7 -* 18.7% at 10 .7 M and 32.2 -* 13.2% at 5  x  10 .7 
M RU-486). This result was obtained in three independent 
experiments, confirming the fetal thymic organ culture results. 
The  adherent  thymic APCs  specifically  stained with  the 
anti-P450scc  serum and produced pregnenolone (data not 
shown).  Furthermore,  simultaneous  fluorescence analysis 
of CD4, CDS, and transgenic TCR o~//3 clonotype expres- 
sion revealed that virtually all of the RU-486-enhanced loss 
of CD4+CD8 + cells was from the population that recog- 
nizes H-Y/H-2 b (data not shown).  Thus, blockade of en- 
dogenously produced steroids, most likely corticosterone, en- 
hances antigen-driven and TCR-mediated thymocyte  deletion. 
Discussion 
Antigen-driven positive selection of developing thymocytes 
is an essential step in the formation of the T  cell antigen- 
specific repertoire. While it is generally believed that it is the 
avidity of TCRs for self antigen/MHC that determines the 
fate of immature thymocytes (no selection and death, posi- 
tive sdection, or negative sdection), the means by which the 
cell "interprets" the avidity of the TCR-ligand interaction 
is unknown. In fact, one of the central paradoxes of thym0- 
cyte selection is that occupancy of one receptor can lead to 
two very different fates, deletion or survival. In its simplest 
form, the mutual antagonism model holds that signals deliv- 
ered upon occupancy of TCRs on immature thymocytes ini- 
tiate a death response, at the same time perhaps promoting 
differentiation toward a more mature state (28). High avidity 
TCR/ligand interactions induce an overwhelming death re- 
sponse, while death signals resulting from low-to-moderate 
avidity TCR/ligand interactions are antagonized by endoge- 
nous corticosteroids, allowing these thymocytes to survive 
and undergo differentiation (positive selection). Thymocytes 
with very low avidity TCR/ligand interactions fail to sur- 
vive, perhaps due to the unopposed effects of corticosteroids. 
The central point of this model is that it is the quantitative 
balance between TCR and glucocorticoid receptor signaling 
that determines the fate of a particular thymocyte~ The results 
in this study support the hypothesis that mutual antagonism 
between TCR-mediated signals and glucocorticoids is one 
Table  3.  Inhibition of Corticosterone Synthesis in Fetal  Thymic Organ  Culture and Effect on Cell Recovery 
Cell recovery 
Corticosterone  H57  Metyrapone  DP  DN  CD4 + CD8 -  CD4- CD8 + 
x  10-* 
-  -  -  75.1  (_+0.4)  1.8  (-+0.4)  7.3  (_+1.0)  1.5  (_+0.3) 
-  +  -  24.8 (-+0.2)  2.3 (_+0.2)  2.6 (_+0.3)  2.2 (,+0.1) 
-  +  +  13.9  (_+0.7)  2.1  (-#0.3)  1.9  (_+0.2)  1.3  (_+0.1) 
+  +  +  25.8 (_+0.8)  2.7 (-+0.4)  2.9 (_+0.3)  2.0 (_+0.1) 
Results are expressed as the arithmetic mean ( •  SEM) of 3-5 individual  thymic lobes per group. Cultures were performed as described in Materials 
and Methods. Total cell recovery was determined by microscopic  enumeration of cells excluding trypan blue, and fractional  recovery of thymocyte 
subsets by flow cytometery. Corticosterone was  added  at  a concentration of I0 -9 M.  DP,  double  positive,  DN, double negative. 
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zymes necessary for steroid and corticosterone production, 
respectively, are expressed in the thymus. Second, radiation- 
resistant thymic epithelium produces pregnenolone, a precursor 
for all other steroids, and deoxycorticosterone~  an intermediate 
in ghcocorticoid synthesis. Finally, prevention of thymic cor- 
ticosterone  production or blockade  of the ghcocorticoid 
receptor greatly enhances TCR-mediated deletion of thymo- 
cytes. Recent data indicate that TCR-ligand interactions that 
normally result in positive selection can be converted to nega- 
tively selecting events by increasing their avidity (39, 40), 
supporting the hypothesis that the outcome of selection (posi- 
tive vs. negative) depends upon where in the continuum the 
avidity for sdf antigen/MHC a particular TCR falls. Gluco- 
corticoid blockade  would not be expected  to affect TCR 
avidity, but would alter the balance between the mutually 
antagonistic stimuli, resulting in unopposed TCR-mediated 
death signals and narrowing the window of TCR avidity 
that results in positive selection. Thus, TCR/glucocorticoid 
mutual antagonism would allow thymocytes with low-to- 
moderate avidity TCRs to survive and proceed to differen- 
tiate towards mature T ceils. A recent report found that in 
vivo injection with RU-486 inhibited anti-CD3-induced de- 
letion of CD4+CD8 + thymocytes  (41), a result seemingly 
at  odds  with our observations  in fetal organ culture and 
antigen-specific thymocyte deletion assays. The reason for this 
difference  is not yet clear, but it may be relevant that the TCR 
specificities  of the deleted cells were not analyzed in that study. 
In vivo injection of anti-CD3, probably due to activation 
of peripheral T ceils and lymphokine secretion, has numerous 
biological effects (42), which may result in increased adrenal 
production  of  glucocorticoids  and  antigen  nonspecific, 
glucocorticoid-mediated ddetion of CD4 +CD8 + thymocytes. 
By using thymic organ culture we avoided this possibility, 
and addressed the specificity of the locally produced steroid 
effect on TCg-mediated deletion by using TCR transgenic 
mice. Use of a similar approach in vivo, or one using V~- 
specific superantigens,  might reconcile the results. 
There are a number of reasons why the thymus might pro- 
duce steroids to supplement those secreted by the adrenals. 
First, circulating levels of glucocorticoids are very low at birth 
(14), a time during which the antigen-spedfic repertoire is 
being established. The ontogeny of thymus steroid produc- 
tion is inverse to that of the adrenal, being highest in the 
fetal/neonatal  period and declining to adult levels by 4 wk 
of age. Second, thymic steroid synthesis may be necessary 
to ensure levds sufficient to fulfill their biological functions. 
Although serum levels  of corticosteroids are in the 500-1,000 
nM range,  the majority is bound to protein (14, 15). The 
level of active unbound (free) corticosterone in plasma is much 
lower, ",~20 nM in adult rats (14). It is possible that locally 
produced steroids, acting as paracrine factors, readily diffuse 
between contacting cells to achieve functionally significant 
intracdlular levels in thymocytes. 
Steroid biosynthesis in the thymus may explain,  at least 
in part, several  previous observations. Whereas adrenalectomy 
before 3 wk has no effect on the thymus, adrenalectomy 
of adult rats leads to hypertrophy (43). This may be because 
corticosteroids produced in the thymus regulate thymocyte 
numbers early in life, but not as endogenous production 
decreases with age. In addition, activated T  lymphocytes 
can secrete ACTH (44, 45), although the levels are too low 
to have a significant effect on adrenal steroidogenesis (46). 
Immunoreactive ACTH has also been detected in thymic 
epithdial cells (20), and carcinoid tumors that secrete ACTH 
arise in the thymus (47). Furthermore, CRF, a hypothalamic 
hormone that induces ACTH production, is synthesized by 
an adherent cell population in the thymus (19). It is possible 
that locally produced CRF/ACTH regulates steroid synthesis 
in the thymus, since P450scc activity in the thymus, as in 
the adrenal, is enhanced by ACTH (Fig. 2 and our unpub- 
lished observations). The finding that thymic epithelial ceils 
produce st~oids raises an intriguing possibih'ty. Bone 
-derived dendritic cells and macrophages in the thymus are 
primarily responsible for negative selection, whereas epithe- 
lial cells mediate positive sdection (2, 48). It is possible that 
antagonism  of TCR-mediated death signals is particularly 
efficient when the APC is a steroid-producing epithelial cell, 
whereas it is less efficient when the APC is a bone marrow-de- 
rived cell that produces no or relatively small amounts of 
steroids. It should be noted, however, that the finding that 
epithelial cell-enriched populations  make steroids does not 
exclude the possibility that other radioresistant thymic cells 
are also capable of steroid synthesis. Further characterization 
of steroid production by thymus cell subsets is needed to clarify 
this issue. 
Previous in vitro data have demonstrated that glucocorti- 
colds antagonize TCR-mediated T cell hybridoma and thymo- 
cyte death. The finding that steroids are produced in the thymic 
microenvironment, and that disruption of this endocrine/para- 
crine pathway has a marked effect on TCR-mediated thymo- 
cyte deletion, strongly supports  the possibility that mutual 
antagonism participates  in deteza,ining the fate of thymo- 
cytes undergoing antigen-driven sdection. Experiments using 
TCR transgenic animals to evaluate what effect endogenous 
steroids might have on generation of the antigen-specific  reper- 
toire are underway. 
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